Point-of-Care Testing of Infectious Diseases: Recent Advances

Point-of-care nucleic acid testing for infectious diseases.

Nucleic acid testing for infectious diseases at the point of care is beginning to enter clinical practice in developed and developing countries; especially for applications requiring fast turnaround times, and in settings where a centralized laboratory approach faces limitations. Current systems for clinical diagnostic applications are mainly PCR-based, can only be used in hospitals, and are st...

In : Recent Advances in Canine Infectious Diseases

In : Recent Advances in Canine Infectious Diseases

Introduction The etiologic agent of canine monocytic ehrlichiosis (CME), the rickettsia Ehrlichia canis (E. canis), is a small pleomorphic gram-negative coccoid bacteria that parasitizes circulating monocytes intracytoplasmically in clusters of organisms called morulae. The disease is also known as canine rickettsiosis, canine hemorrhagic fever, tracker dog disease, canine tick typhus, Nairobi ...

Recent Advances of Vaccine Adjuvants for Infectious Diseases

Vaccines are the most effective and cost-efficient method for preventing diseases caused by infectious pathogens. Despite the great success of vaccines, development of safe and strong vaccines is still required for emerging new pathogens, re-emerging old pathogens, and in order to improve the inadequate protection conferred by existing vaccines. One of the most important strategies for the deve...

Paediatric infectious diseases: some recent advances and future priorities.

Infectious diseases present an ever changing panorama. While change and advance are not synonymous, changes in human behaviour-by presenting urgent new dilemmas-may lead to advances in understanding of disease and its transmission. The first decade of awareness of the illness now known to be due to the human immunodeficiency virus (HIV) will have been remarkable in this respect. Some of the adv...